Comprehensive coverage

Byline

Biotechnology. Illustration: shutterstock

Biotechnology Cluster: Pluristem received the approval of the US Registrar for a key patent of the company

  • No comments

Bioline R.X has completed the recruitment of patients for phase 2b of the clinical trials for a new drug for the treatment of schizophrenia

  • No comments

Beauline R. X advances a step in approving a drug to treat heart attacks

  • 2 תגובות

Can seaweed mend a broken heart?

  • 3 תגובות

Bioline R.X. Announces Initiation of Phase II Human Clinical Trials of BL-1020, a New Drug for the Treatment of Schizophrenia

  • No comments

Bioline R.X. Launches a program for advanced development

  • No comments

Bioline R.X. Begins clinical trials to test the effectiveness of BL-1020, an antipsychotic drug for the treatment of schizophrenia

  • 4 תגובות

Beauline R. Ex. Signed a licensing agreement with the Hebrew University and Tel Aviv University for a potential drug to treat inflammatory diseases

  • 5 תגובות

Licensing agreement for Bioline R. Ex. With Bo Gurion University and with the general medicine for anti-inflammatories

  • No comments

The technological incubators committee approved the establishment of a biotechnological incubator in Jerusalem

  • No comments
Science website logo
SEARCH